IL6R and rheumatoid arthritis: The pathophysiology of autoimmunity however, is complex, explaining the observations that certain therapeutic strategies are effective in some AIDs (e.g., IL-6R blockade in RA [10]), while exhibiting no benefit in others (e.g., IL-6R blockade in AS [111]).